Articles

Choosing the Right Therapy for Patients with NSCLC

Dr. Edward Garon explains how he discusses immunotherapies with patients.

Differences in NSCLC Patient Populations

Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice.

ALK Gene Rearrangement and PD-L1 Expression

Dr. Edward Garon speaks about how differences in patient populations with lung cancer can make it difficult to interpret and act on data.

A Look at PD-1 and PD-L1 Inhibitors

Dr. Edward Garon does not believe there is much value in utilizing PD-L1 inhibitors for pateints with ALK gene rearrangement.

Shifts in Lung Cancer Treatment

Dr. Edward Garon discusses the use of PD-1 and PD-L1 inhibitors in patients with lung cancer.

Common Presenting Factors for NSCLC

Dr. Edward Garon reviews how certain drugs can change the landscape for treating patients with lung cancer.

Who Should be Screened for Lung Cancer?

Dr. Edward Garon provides an overview of the most common presenting clinical features in adults with non-small cell lung cancer (NSCLC).

Screening for Lung Cancer

Dr. Edward Garon identifies the target population for lung cancer screening.